Literature DB >> 10589386

Obesity: effects on the liver and gastrointestinal system.

C H Halsted1.   

Abstract

Obesity, or the presence of a body mass index exceeding 30 kg/m2, has assumed epidemic proportions in the United States. More than a cosmetic issue, obesity is associated with many comorbidities that contribute to multiple organ dysfunction, illness, and shortened life span. This review covers new and emerging information on the relationship of obesity to common and debilitating hepatic and gastrointestinal disorders, including nonalcoholic steatohepatitis, gastroesophageal reflux, gallstones, and increased risk of colon cancer. Understanding the role of obesity in these disorders should lead to new insights into the pathogenesis of common liver and gastrointestinal diseases and to new treatment strategies for the practicing gastroenterologist.

Entities:  

Mesh:

Year:  1999        PMID: 10589386     DOI: 10.1097/00075197-199909000-00012

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  4 in total

1.  Impacts of common factors of life style on serum liver enzymes.

Authors:  Joanna Danielsson; Päivikki Kangastupa; Tiina Laatikainen; Mauri Aalto; Onni Niemelä
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

2.  Effects of Obesity on Pro-Oxidative Conditions and DNA Damage in Liver of DMBA-Induced Mammary Carcinogenesis Models.

Authors:  Stepan Melnyk; Soheila Korourian; Joseph W Levy; Oleksandra Pavliv; Teresa Evans; Reza Hakkak
Journal:  Metabolites       Date:  2017-06-08

3.  Individual and joint impacts of ethanol use, BMI, age and gender on serum gamma-glutamyltransferase levels in healthy volunteers.

Authors:  Joanna Danielsson; Päivikki Kangastupa; Tiina Laatikainen; Mauri Aalto; Onni Niemelä
Journal:  Int J Mol Sci       Date:  2013-06-04       Impact factor: 5.923

Review 4.  Biomarker-Based Approaches for Assessing Alcohol Use Disorders.

Authors:  Onni Niemelä
Journal:  Int J Environ Res Public Health       Date:  2016-01-27       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.